News
The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...
3don MSN
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...
Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...
That controversial Super Bowl ad appears to have paid off for Hims & Hers as the company's first-quarter revenue doubled year ...
4don MSN
CVS Health said it will significantly expand access to Novo Nordisk's blockbuster weight loss drug Wegovy for patients ...
3don MSN
A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...
3h
Her Campus on MSNWhat Gen Z College Students Need To Know About GLP-1s & Weight Loss SurgeryWeight loss medications and bariatric surgery used to be considered last-resort options, but now, they’re everywhere. More ...
The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...
A decision is expected in the fourth quarter of 2025.
Weight loss pills either reduce appetite, boost metabolism or block fat absorption. Most people lose 5% to 10% of their body ...
Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results